DWP14012-based triple therapy

DWP14012 · Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DWP14012-based triple therapy, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori [Phase 3]

See pricing